Search Results

Filter
  • 1-10 of  34,895 results for ""BLOOD coagulation factors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal.

Subjects: Anticoagulation Reversal* ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/adverse effects ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use

  • Source: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Mar-Apr; Vol. 64 (2), pp. 395-401. Date of Electronic Publication: 2023 Nov 11.Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Fixed- Versus Variable-Dose Prothrombin Complex Concentrate for the Emergent Reversal of Vitamin K Antagonists: A Systematic Review and Meta-Analysis.

  • Authors : Alwakeal A; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.; Maas MB

Subjects: Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/drug therapy ; Thromboembolism*/Thromboembolism*/Thromboembolism*/prevention & control

  • Source: Critical care medicine [Crit Care Med] 2024 May 01; Vol. 52 (5), pp. 811-820. Date of Electronic Publication: 2024 Feb 14.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0355501 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Hemostasis Using Prothrombin Complex Concentrate in Patients Undergoing Cardiac Surgery: Systematic Review with Meta-Analysis.

  • Authors : Li JP; Medical Oncology, Zibo Municipal Hospital, Zibo, Shandong, People's Republic of China.; Li Y

Subjects: Atrial Fibrillation* ; Cardiac Surgical Procedures* ; Myocardial Infarction*

  • Source: Brazilian journal of cardiovascular surgery [Braz J Cardiovasc Surg] 2024 Apr 03; Vol. 39 (2), pp. e20230076. Date of Electronic Publication: 2024 Apr 03.Publisher: Brazilian Society of Cardiovascular Surgery Country of Publication: Brazil NLM ID: 101677045 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage.

Subjects: Anticoagulants*/Anticoagulants*/Anticoagulants*/therapeutic use ; Blood Coagulation Factors* ; Factor Xa*

  • Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.

  • Authors : Buka RJ; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. .; Sutton DJ

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use ; Veterans* ; Blood Coagulation Factors*

  • Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2024 Apr; Vol. 57 (4), pp. 739-741. Date of Electronic Publication: 2024 Feb 15.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Electrospun Composite PLLA-PPSB Nanofiber Nerve Conduits for Peripheral Nerve Defects Repair and Regeneration.

  • Authors : Dai Y; Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, 200040, China.; Lu T

Subjects: Nanofibers*/Nanofibers*/Nanofibers*/therapeutic use ; Nanofibers*/Nanofibers*/Nanofibers*/chemistry ; Peripheral Nerve Injuries*/Peripheral Nerve Injuries*/Peripheral Nerve Injuries*/drug therapy

  • Source: Advanced healthcare materials [Adv Healthc Mater] 2024 Apr; Vol. 13 (10), pp. e2303539. Date of Electronic Publication: 2024 Feb 05.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659

Record details

×
Academic Journal

4-Factor Prothrombin Complex Concentrate Dosing Strategies: A Retrospective Evaluation.

  • Authors : Reachi B; Department of Pharmacy, Intermountain Medical Center, Murray, UT, USA.; Negrelli J

Subjects: Blood Coagulation Factors* ; Hemorrhage*/Hemorrhage*/Hemorrhage*/chemically induced ; Hemorrhage*/Hemorrhage*/Hemorrhage*/drug therapy

  • Source: Journal of pharmacy practice [J Pharm Pract] 2024 Apr; Vol. 37 (2), pp. 287-295. Date of Electronic Publication: 2022 Oct 07.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and efficacy of fixed versus variable-dose prothrombin complex concentrate for emergent reversal of vitamin K antagonists: A systematic review and meta-analysis.

  • Authors : Condeni MS; Medical University of South Carolina, MUSC Health, Department of Pharmacy, 150 Ashley Avenue, Charleston, SC 29425, United States of America. Electronic address: .; Weant KA

Subjects: Vitamin K* ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use; Humans

  • Source: The American journal of emergency medicine [Am J Emerg Med] 2024 Mar; Vol. 77, pp. 91-105. Date of Electronic Publication: 2023 Dec 10.Publisher: W B Saunders Country of Publication: United States NLM ID: 8309942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial.

  • Authors : Greze J; Inserm, U1216, CHU Grenoble Alpes, Grenoble Institute Neurosciences, Univ. Grenoble Alpes, 38000, Grenoble, France.; Marlu R

Subjects: Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/adverse effects ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Thrombin*/Thrombin*/Thrombin*/drug effects

  • Source: Critical care (London, England) [Crit Care] 2024 Feb 19; Vol. 28 (1), pp. 51. Date of Electronic Publication: 2024 Feb 19.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal.

  • Authors : Brett S; Department of Pharmacy, UPMC Mercy, Pittsburgh, PA, USA.; Taylor M

Subjects: Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/administration & dosage ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/therapeutic use ; Blood Coagulation Factors*/Blood Coagulation Factors*/Blood Coagulation Factors*/pharmacology

  • Source: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2024 Jan-Dec; Vol. 30, Publisher: Sage Publications Country of Publication: United States NLM ID: 9508125 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  34,895 results for ""BLOOD coagulation factors""